Altice USA [ATUS] vs Cogent [CCOI] Detailed Stock Comparison
Altice USA
NYSE
Loading...
Cogent
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Altice USA wins in 15 metrics, Cogent wins in 3 metrics, with 0 ties. Altice USA appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Altice USA | Cogent | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 188.00 | 105.01 | Cogent |
| Price-to-Book Ratio | -1.78 | 38.25 | Altice USA |
| Debt-to-Equity Ratio | -40.85 | 5,741.03 | Altice USA |
| PEG Ratio | -0.24 | 1.35 | Altice USA |
| EV/EBITDA | 8.16 | 30.01 | Altice USA |
| Profit Margin (TTM) | -3.07% | -23.46% | Altice USA |
| Operating Margin (TTM) | 17.18% | -13.90% | Altice USA |
| EBITDA Margin (TTM) | 17.18% | N/A | N/A |
| Return on Equity | 22.53% | -93.59% | Altice USA |
| Return on Assets (TTM) | 3.03% | -3.08% | Altice USA |
| Free Cash Flow (TTM) | $149.39M | $-203.64M | Altice USA |
| Dividend Yield | N/A | 15.42% | N/A |
| 1-Year Return | 29.89% | -47.37% | Altice USA |
| Price-to-Sales Ratio (TTM) | 0.12 | 2.00 | Altice USA |
| Enterprise Value | $26.33B | $4.25B | Altice USA |
| EV/Revenue Ratio | 3.01 | 4.61 | Altice USA |
| Gross Profit Margin (TTM) | 69.14% | 44.17% | Altice USA |
| Revenue per Share (TTM) | $19 | $19 | Cogent |
| Earnings per Share (Diluted) | $-0.58 | $-4.52 | Altice USA |
| Beta (Stock Volatility) | 1.56 | 0.65 | Cogent |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Altice USA vs Cogent Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Altice USA | 5.29% | 0.84% | -14.03% | 5.29% | -14.95% | 0.84% |
| Cogent | 2.29% | 12.06% | -22.29% | -16.38% | -51.48% | -50.21% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Altice USA | 29.89% | -76.41% | -91.27% | -93.03% | -93.03% | -93.03% |
| Cogent | -47.37% | -30.23% | -41.77% | 39.77% | 322.69% | 654.03% |
Performance & Financial Health Analysis: Altice USA vs Cogent
| Metric | ATUS | CCOI |
|---|---|---|
| Market Information | ||
| Market Cap | $1.03B | $1.85B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 3,539,090 | 2,712,670 |
| 90 Day Avg. Volume | 4,086,140 | 1,481,807 |
| Last Close | $2.39 | $38.38 |
| 52 Week Range | $1.70 - $3.20 | $29.62 - $86.76 |
| % from 52W High | -25.31% | -55.76% |
| All-Time High | $38.30 (Dec 28, 2020) | $110.00 (Feb 04, 2002) |
| % from All-Time High | -93.76% | -65.11% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.04% | -0.06% |
| Quarterly Earnings Growth | -0.04% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | -0.03% | -0.23% |
| Operating Margin (TTM) | 0.17% | -0.14% |
| Return on Equity (TTM) | 0.23% | -0.94% |
| Debt to Equity (MRQ) | -40.85 | 5,741.03 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-1.33 | $0.98 |
| Cash per Share (MRQ) | $0.53 | $4.50 |
| Operating Cash Flow (TTM) | $1.48B | $-13,381,000 |
| Levered Free Cash Flow (TTM) | $537.92M | $-170,508,752 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 15.42% |
| Last 12-Month Dividend | $0.00 | $4.99 |
Valuation & Enterprise Metrics Analysis: Altice USA vs Cogent
| Metric | ATUS | CCOI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 188.00 | 105.01 |
| Forward P/E | 73.33 | -10.84 |
| PEG Ratio | -0.24 | 1.35 |
| Price to Sales (TTM) | 0.12 | 2.00 |
| Price to Book (MRQ) | -1.78 | 38.25 |
| Market Capitalization | ||
| Market Capitalization | $1.03B | $1.85B |
| Enterprise Value | $26.33B | $4.25B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.01 | 4.61 |
| Enterprise to EBITDA | 8.16 | 30.01 |
| Risk & Other Metrics | ||
| Beta | 1.56 | 0.65 |
| Book Value per Share (MRQ) | $-1.33 | $0.98 |
Financial Statements Comparison: Altice USA vs Cogent
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ATUS | CCOI |
|---|---|---|
| Revenue/Sales | $2.15B | $247.05M |
| Cost of Goods Sold | $670.53M | $137.44M |
| Gross Profit | $1.48B | $109.61M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $365.08M | $-40.29M |
| EBITDA | $782.60M | $40.86M |
| Pre-Tax Income | $-87.24M | $-70.26M |
| Income Tax | $-15.96M | $-18.22M |
| Net Income (Profit) | $-71.27M | $-52.04M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ATUS | CCOI |
|---|---|---|
| Cash & Equivalents | $279.14M | $153.81M |
| Total Current Assets | $769.34M | $422.68M |
| Total Current Liabilities | $2.15B | $283.42M |
| Long-Term Debt | $25.42B | $2.28B |
| Total Shareholders Equity | $-526.19M | $142.84M |
| Retained Earnings | $-779.67M | $-477.52M |
| Property, Plant & Equipment | $17.69B | $3.75B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ATUS | CCOI |
|---|---|---|
| Operating Cash Flow | $336.38M | $36.73M |
| Capital Expenditures | N/A | $-58.09M |
| Free Cash Flow | $-168.64M | $-21.74M |
| Debt Repayment | $-237.28M | $-8.00M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ATUS | CCOI |
|---|---|---|
| Shares Short | 32.33M | 4.91M |
| Short Ratio | 6.21 | 8.80 |
| Short % of Float | 0.42% | 0.15% |
| Average Daily Volume (10 Day) | 3,539,090 | 2,712,670 |
| Average Daily Volume (90 Day) | 4,086,140 | 1,481,807 |
| Shares Outstanding | 463.20M | 49.03M |
| Float Shares | 264.36M | 46.31M |
| % Held by Insiders | 0.07% | 0.02% |
| % Held by Institutions | 1.08% | 1.02% |
Dividend Analysis & Yield Comparison: Altice USA vs Cogent
| Metric | ATUS | CCOI |
|---|---|---|
| Last 12-Month Dividend | $0.00 | $4.99 |
| Last 12-Month Dividend Yield | N/A | 15.42% |
| 3-Year Avg Annual Dividend | $0.00 | $4.17 |
| 3-Year Avg Dividend Yield | N/A | 1.65% |
| 3-Year Total Dividends | $0.00 | $12.51 |
| Ex-Dividend Date | N/A | Aug 21, 2025 |